Sarah Schuller
Psychiatric/Mental Health · Ankeny, IANPI 1407463292
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,206, 2.2 times the $1,458 reported in 2021. Among psychiatric/mental health clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 565 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$857
- Lundbeck LLC$837
- Corium, LLC$766
- plus $4K from 18 others
What the payments were for
- Food & beverage$11,713100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 60 | $1,895 |
| AbbVie | 115 | $1,864 |
| Otsuka America Pharmaceutical, Inc. | 56 | $1,150 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $857 |
| Lundbeck LLC | 41 | $837 |
| Corium, LLC | 25 | $766 |
| Supernus Pharmaceuticals, Inc. | 43 | $764 |
| Neuronetics, Inc. | 9 | $476 |
| Teva Pharmaceuticals USA, Inc. | 19 | $423 |
| Vanda Pharmaceuticals Inc. | 16 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $337 |
| Axsome Therapeutics, Inc. | 9 | $310 |
| Ironshore Pharmaceuticals Inc. | 23 | $307 |
| MDD US Operations, LLC | 23 | $214 |
| Tris Pharma Inc | 17 | $197 |
| E.r. Squibb & Sons, L.L.C. | 8 | $183 |
| Alkermes, Inc. | 9 | $174 |
| Neos Therapeutics, LP | 8 | $145 |
| Almatica Pharma LLC | 5 | $114 |
| Itamar Medical Inc | 2 | $109 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Noven Therapeutics, LLC | 3 | $52 |
| Biogen | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$929
- QELBREE$405
- Azstarys$252
- REXULTI$231
- NEUROSTAR TMS THERAPY$222
- Auvelity$122
- NEUROSTAR TMS THERAPY SYSTEM$114
How this compares
$11,720 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $2,006 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $427 |
| Trazodone Hcl | 24 | $352 |
| Hydroxyzine Pamoate | 16 | $263 |
| Clonidine Hcl | 16 | $260 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $131 |
| Clonazepam | 16 | $111 |
| Prazosin Hcl | 17 | $110 |
| Duloxetine Hcl | 18 | $96 |
| Lamotrigine | 14 | $50 |
| Lorazepam | 18 | $32 |
| Sertraline Hcl | 16 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $114 | $616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Ankeny
- Shyrl HoagAnkeny$8K
- Michelle HancockAnkeny$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.